Latest News
Partech has promoted André François-Poncet to partner and appointed Elena Moneta as principal in the Venture team.
Based in Paris, François-Poncet has been a major contributor over his seven years with the firm. He has been instrumental in the investments of Partech Growth including Made.com (IPO in June 2021), Brandwatch (acquired by Cision in 2021), EcoVadis, M-Files, Sendinblue and more recently Skello and Weglot.
Moneta’s six years of experience span across investment banking, venture investing and start-up operations. Prior to joining Partech, she was a venture capital investor in London at early-stage VC firm Hambro Perks, where she focused
BaltCap, together with lead investor Novator Ventures, General Catalyst and Burda Principal Investments, has participated in a USD100 million financing round in Nord Security, a global specialist in internet privacy and security solutions.
Fidel API, a global financial infrastructure platform, has raised USD65 million in a Series B funding.
Existing investors NYCA Partners, QED Investors and others also participated in the round which brings Fidel API’s total funding to USD88 million since inception.
The Series B financing will allow the company to continue to scale its workforce and product offerings and will also accelerate investments into existing products.
Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured EUR3.5 million in a funding round led by European life science venture fund Hadean Ventures and joined by Scale Capital and Bonit Capital.
Alex Therapeutics aspires to become the global go-to partner for pharma, and other life-science companies seeking to develop and launch DTx solutions. These digital health products are validated in clinical trials and prescribed by a doctor, similar to traditional therapeutics. This funding round will be used to accelerate Alex’s growth in Europe and the US and to develop novel DTx products alongside both new and
AmerisourceBergen, a healthcare solutions company, has launched AB Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with emerging healthcare startup companies working to transform healthcare for people and animals globally.
AB Health Ventures will build on AmerisourceBergen’s ongoing commitment to delivering innovation for its customers.
AB Health Ventures will initially launch with USD150 million allocated for investment in early-to mid-stage health-related startups around the world. The fund will prioritise investments in entrepreneurs who are pursuing bold ideas in areas such as the future of pharmacy and distribution, clinical development and commercialisation of pharmaceuticals, practice
illumifin, a third-party insurance administration and technology provider, has completed its acquisition of LTCG to create one of the largest insurance service providers in the North American long-term care, life, health, and annuity markets.
LTCG’s proprietary long-term care administration solutions and claims capabilities will be integrated with illumifin’s third-party administration and technology platform. This combination will deliver end-to-end digital capabilities driving value to insurance companies.
illumifin was founded by Abry Partners, a Boston-based private equity firm, and Hoplon Capital, an asset manager focused on digital disruption, after the acquisition of Concentrix Corporation’s insurance third-party administration and software platform.
Lead Edge Capital (LEC), a technology-focused growth stage investment fund, has closed Fund VI, which was oversubscribed, with over USD1.95 billion of commitments from Lead Edge’s network of over 500 limited partners and institutions.
LEC will target making equity investments of between USD15 million and USD200 million per portfolio company from Fund VI and continue its focus on investing primarily in private companies, with a flexible mandate that also enables public company investments. The addition of Fund VI brings the firm’s total capital raised since inception to USD5 billion.
LEC’s Limited Partners come from companies including Charles Schwab, Capital One,
Postclick, the company behind the Advertising Conversion Cloud, has raised USD20 million in a funding round led by Bridge Bank’s Technology Banking Group.
Postclick will use the funding to support the company’s evolution from an agency model to a full technology-led SaaS solution that will continually develop new innovations as an advanced partner to the marketing industry. The funds will also advance Postclick’s machine learning and artificial intelligence offerings, as well as deepen the company’s penetration into vertical markets.
Global alternative investment manager Ares Management Corporation (Ares), has launched the Ares Private Markets Fund, a new registered, continuously offered, non-traded, closed-end fund that intends to invest in an actively managed portfolio of private equity and other private assets principally through secondary market fund investments, and, to a lesser degree, primary fund investments and direct co-investments.
The Fund has been launched with more than USD250 million in initial capital, including investments from two significant institutional investors as well as a USD75 million investment directly from Ares.
Leveraging the strength of the global Ares platform and the depth of Ares’ Secondary
Global investment firm Carlyle has made the final close of its second Carlyle Credit Opportunities Fund (CCOF II) which raised USD4.6 billion, hitting its hard cap, exceeding its USD3.5 billion target, and attracting almost double the amount raised for its predecessor fund.
Including available leverage, investable capital is approximately USD6 billion.
CCOF II provides capital solutions to companies seeking an alternative to traditional capital markets or private equity. Its directly originated solutions are targeted at upper middle market borrowers, including family and entrepreneur-owned businesses, sponsor-backed companies and asset-backed borrowers.
CCOF II has already committed approximately USD3.8 billion—or 6
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
